At the time, President Donald Trump touted the focus on accelerating the development of vaccines with the help of the private sector. “My administration provided a total of $14 billion to accelerate vaccine development and to manufacture all of the top [COVID vaccine] candidates in advance,”...
Updated COVID-19 vaccine shots are expected to be available nationwide as soon as Sept. 13, after a panel of the Centers for Disease Control and Prevention's outside vaccine advisers voted by a wide majority to back new shots retargeted for newer variants ahead of the fall virus season. ...
Health officials have long acknowledged that the rollout of this year's new COVID-19 vaccines would likely arrive too late for many Americans infected by this summer's wave of the virus. "It's very difficult to try to time COVID vaccine before an oncoming surge. And so I think what we...
In its analysis of Pfizer's data, the FDA said that rates of hospitalization and death due to COVID-19 among children under 5 were higher than among those aged 5 to 17, "underscoring the benefit of an effective COVID-19 vaccine in this age group." The FDA also noted that among childr...
Right now, these adverse events appear to be extremely rare. COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously. People who have received the J&J vaccine who develop severe headache,...
J&J's Covid-19 vaccine, like Pfizer's and Moderna's shots, received an emergency use authorization from the FDA to start distributing the doses across the U.S. An EUA grants conditional clearance based on two months of safety data, pending another submission for full...
Moderna COVID‑19 Vaccine是ModernaTX公司研发的新冠肺炎疫苗,用以引起18岁及以上人群免疫预防COVID-19。FDA于2020年12月18日为其签发EUA授权。 Moderna COVID-19 Vaccine是一种用于肌肉注射的悬浮液,分为两剂(每剂0.5 mL),间隔1个月。产品小瓶需要保存在-25ºC至-15ºC之间避光冷冻保存。
In addition to Pfizer releasing its data, Moderna announced on Monday its Covid-19 vaccine was almost 95% effective in preventing the disease, based on preliminary results. The Massachusetts-based biotech firm said it would apply for emergency use authorization with the FDA in the coming weeks...
The safety of a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent for individuals 12 years of age and older is based on safety data from a clinical study which evaluated a booster dose of Pfizer-BioN...
The FDA has approved emergency use of a third COVID-19 vaccine from Johnson & Johnson’s Janssen Biotech unit, the day after an advisory committee concluded it was safe and effective. Janssen’s Ad26.COV2.S vaccine has been authorised for use in people a